...Inc. (NASDAQ:GBT) and Welsh is general counsel and president of the North America unit of Royal DSM N.V....
...at Cargill Inc. (Minneapolis, Minn.). Elizabeth S. Eaton, Staff Writer Biotechnology Innovation Organization Global Blood Therapeutics Inc. Ovid Therapeutics Inc. Royal DSM N.V. Hugh...

...acquired the DSM Sinochem Pharmaceuticals Ltd. JV of Royal DSM N.V. (Euronext:DSM) and Sinochem Group (Beijing, China). Royal DSM...
...eligible to receive a €50 million ($59 million) earnout. Further financial terms were not disclosed. Royal DSM...
...treatments and beta lactamase (LACTB) inhibitors for LACTB-producing pathogens (see "Royal DSM, Sinochem Group Deal" ). Royal DSM N.V....

...raised $47 million in the first tranche of a planned $95 million private placement from Royal DSM...

...OptiBiotix and Royal DSM partnered to develop products to treat microbiome-associated diseases, including diabetes and obesity, using...
...areas where the company already markets its products. Royal DSM’s food-related products include vitamins and nutraceuticals. Royal DSM...
...are not disclosed. Royal DSM did not respond to inquiries. OptiBiotix Health plc (LSE:OPTI), York, U.K. Royal DSM N.V....

...oral business. He was global VP of operational excellence at the Patheon Inc. unit of Royal DSM N.V....

...cash, which the partners said gave the CRO an enterprise value of about $2 billion. Royal DSM...
...and 49% owned by Royal DSM (see BioCentury, Nov. 25, 2013). Patheon Inc. , Durham, N.C. Royal DSM N.V....

...on Nov. 18, before the deal was announced. The partners plan to combine Patheon with Royal DSM's...
...and Simpson Thacher & Bartlett are legal advisors to JLL. Patheon Inc. (TSX:PTI), Durham, N.C. Royal DSM N.V....

...Dutch chemicals company Royal DSM N.V. (Euronext:DSM) and private equity firm JLL Partners are teaming up to acquire...
...C$5.94 on Monday, before the deal was announced. The partners plan to combine Patheon with Royal DSM's...

...Research and Development Authority (BARDA) awarded contracts to Cook's Cook Pharmica subsidiary, JHP, Nanotherapeutics and Royal DSM's...
...Inc. , Bloomington, Ind. JHP Pharmaceuticals LLC , Parsippany, N.J. Nanotherapeutics Inc. , Alachua, Fla. Royal DSM N.V....

...BioCentury, Feb. 12, 2007 & Oct. 11, 2010). Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Royal DSM N.V....